Ameliorated Chemotherapeutic Potential of Diverse Dose Flouropyrimidine Therapy By Etodolac via NF-?B Pathway, PPAR-? Expression and COX-II Inhibition in DMH Induced Colon Cancer Rats

By  

Clinical Cancer Drugs, Vol. 3, Iss. 2, 2016-10 ,pp. : 109-120

Bentham Science Publishers

Access to resources Recommend Favorite

LPS Up-Regulates Cystathionine γ -Lyase Gene Expression in Primary Human Macrophages via NF-ΚB/ERK Pathway

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 14, Iss. 2, 2015-04 ,pp. : 99-104

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the NF-ΚB pathway in prostate cancer: a promising therapeutic approach?

By  

Current Drug Targets, Vol. 17, Iss. 3, 2016-03 ,pp. : 311-320

Bentham Science Publishers

Access to resources Recommend Favorite

Pioglitazone, a PPAR-γ ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-κB-cytokine cascade

By  

Redox Report, Vol. 17, Iss. 1, 2012-01 ,pp. : 47-47

Maney Publishing

Access to resources Recommend Favorite

Telmisartan Blocks Advanced Glycation End Product (AGE)-Induced Plasminogen Activator Inhibitor-1 (PAI-1) Gene Expression in Endothelial Cells via Activation of Peroxisome Proliferator-Activated Receptor-&ggr; (PPAR-&ggr; )

By  

Letters in Drug Design & Discovery, Vol. 5, Iss. 8, 2008-12 ,pp. : 477-480

Bentham Science Publishers

Access to resources Recommend Favorite